Washington State Medical Oncology Society (WSMOS)
Virtual Summer Conference Series July 2, 2020
WSMOS Virtual Summer Conference Series July 2, 2020
July 2, 2020
|6pm – 8pm|
What Do We Have, What Do We Want, and Why Do We Want It
Join Jennie Crews, MD, Sibel Blau, MD and Jeffery Ward, MD, in a discussion on how the COVID-19 pandemic is transforming telehealth, how oncology clinics are integrating telehealth in their practice today, and what telehealth should look like after COVID-19.
We would like to encourage all of our Hematology and Oncology colleagues in the state of Washington, including Physicians, Fellows, Emeritus, Office Managers, Administrators, Pharmacists, NP’s, PA’s, and RN’s to have your voices heard. With your support, WSMOS will continue to be the leading professional organization for oncologists in the state of Washington and a resource for the oncology community through professional education, and information dissemination.
Membership is critical to the continued advancement of WSMOS interests:
- To identify and work to improve oncology practice issues that adversely affect patient access to cancer care.
- To act as a patient advocate to assure that patients have access to the best available care.
- To support and encourage clinical research against cancer. To learn more about joining the WSMOS please contact email@example.com.
Speakers - June 25, 2020
Catherine Liu, MD
Infectious Disease specialistDr. Catherine Liu is an infectious disease specialist at Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance. She graduated from UCSF School of Medicine, completed her residency in Internal Medicine at Massachusetts General Hospital, and her ID fellowship at UCSF. She is an Associate Professor at University of Washington and Fred Hutchinson Cancer Research Center and Director of the Antimicrobial Stewardship Program and Associate Director of Infection Prevention at Seattle Cancer Care Alliance. She specializes in management of infections in immunocompromised hosts including oncology and hematopoietic stem cell transplant recipients.
Steven Pergam, MD, MPH
Medical Director – Infection Prevension
Dr. Pergam received his MD from the University of Nebraska, his Infectious Diseases training at the University of Washington (UW), and his MPH from the UW School of Public Health. He is currently an Associate Member in the Clinical Research and Vaccine and Infectious Disease Divisions at the Fred Hutchinson Cancer Research Center. He is also an Associate Professor in the Division of Allergy & Infectious Diseases, and an Adjunct Associate Professor in the Dept. of Epidemiology at the UW School of Public Health.
Dr. Pergam serves as the Medical Director of Infection Prevention at the Seattle Cancer Care Alliance (SCCA), where he and his staff have developed a robust program to protect cancer and transplant recipients against major healthcare-associated infections (HAI). Dr. Pergam is actively involved in the development of new infection control strategies and educational programs, and has research projects that aim to better understand the epidemiology of nosocomial bacterial infections and respiratory viruses in high-risk immunocompromised hosts.
Michael Bolton, MD, PhD
Infectious Disease PractitionerDr. Michael Bolton is an infectious disease practitioner. He graduated from UCSF School of Medicine in 2006, completed his residency in Internal Medicine at Emory University, and his Fellowship at University of Washington. Dr. Bolton is board certified in Internal Medicine and Infectious Disease. He specializes in general infectious disease, HIV management and prevention, and travel and tropical medicine.immunocompromised hosts.
Speakers - July 2, 2020
Jennie Crews, MD
Medical Director – Seattle Cancer Care Alliance NetworkDr. Crews is Medical Director for the Seattle Cancer Care Alliance Network, Administrative and Medical Director for SCCA Community Sites and a Clinical Associate Professor of Medicine at the University of Washington. Her clinical focus is Survivorship. Dr. Crews received her B.S. in Biology with highest honors from UNC- Chapel Hill and completed her MD and oncology fellowship at Duke University. She earned a Master in Medical Management from the University of Southern California. Dr. Crews was President of the Association of Community Cancer Centers from 2016-2017 and is Editor-in-Chief of ACCC’s Oncology Issues. She is a reviewer for the ASCO-SEP and has Co-Chaired the ASCO Practice Guidelines Implementation Network. She is the current President of the Washington State Medical Oncology Society.
Sibel Blau, MD
Dr. Sibel Blau is a Medical Oncologist who has been in clinical practice since 2001 after completion of her Stem Cell fellowship at Fred Hutchinson Cancer Research Center. In addition to her work as a breast oncologist, Dr. Blau has taken leadership roles in developing breast cancer program of excellence in her region. She is also very involved with clinical research program at Northwest Medical Specialties where she is the Medical Director for Hematology-Oncology division and is the head of the Precision Medicine program.
She is one of the founding members and the President/CEO of the Quality Cancer Care Alliance Network that is a national organization to form a value based care organization to improve the cost and quality of cancer patients treated in independent practices throughout the nation. She is also the immediate past President of Washington State Medical Oncology Society (WSMOS), and a member of All4cure as a Clinical Oncologist.
Jeffery Ward, MD
Jeffery C. Ward, MD is a board certified medical oncologist/hematologist at the Swedish Cancer Institute in Edmonds, Washington. A graduate of the University of Washington School of Medicine, and residency and fellowship trained at the University of Minnesota, he has provided cancer and hematology care in the Edmonds Community since 1993. Also board certified in hospice and palliative care and has been a medical director for Providence Hospice of Snohomish County for over 20 years.
Dr. Ward has been an active advocate for community based cancer care in Washington State as past-president and board member of the Washington State Medical Oncology Society. Nationally, he served on ASCO’s Clinical Practice Committee from 2008 to 2014 and Government Relations Committee from 2014 to 2020, chairing both committees. Dr. Ward led ASCO in its development of a State Affiliate Council and is a recognized expert in oncology reimbursement reform. He has been an Associate Editor of the JCO Oncology Practice for nine years. Dr. Ward is a proponent of evidence based personalized therapeutics and value based clinical pathways to provide high quality affordable cancer care in the communities where patients live and work.